LIVE
Real-Time
NEWS MONITOR
--:--:--
⬤ LOW 11 Aug 2026, 20:00 UTC

Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock

This problem has a solution, and Pfizer is implementing it.
TECH MARKETS
\
↗ Read Full Story ← Back to Monitors
Share: Twitter/X LinkedIn
Latest in Markets
⬤ LOW
Nike recortará puestos de trabajo y prevé una caída de los ingresos el próximo año
Expansion (Spain) · 4 min ago
⬤ LOW
Norfolk Southern: The Spread Says Wait, Not Walk Away
Seeking Alpha · 4 min ago
⬤ LOW
We’re Speaking to Don Wilson at Odd Lots LIVE in Chicago
Bloomberg Markets · 7 min ago
⬤ LOW
CARIBBEAN AIRLINES ENHANCES NETWORK OPERATIONS WITH SERVICES TO TORONTO, CARACAS AND PANAMA
Financial Post · 7 min ago
⬤ LOW
Mr. Eric Krafft Reports Participation on the Private Placement of Leading Edge Materials Corp.
Financial Post · 8 min ago
Terms of Service